Trans-dermal Form of Combined HormonalContraception (EVRA®)
Gynekologicko-porodnická klinika 1. LF UK a VFN v Praze, přednosta prof. MUDr. J. Živný, DrSc.
Čes. Gynek.2003, , č. 5 s. 341-345
To present a review of a novel transdermal contraceptive patch containing norelgestromin(150 g/d) and ethinylestradiol (20 g/d).Design: Review article.Setting: Department of Gynecology and Obstetric, 1st Medical Faculty and General Faculty Hospital,Prague.Results: The contraceptive patch exhibits favourable pharmakokinetic profile, maintaining efficaciousserum hormone concentrations under varying conditions and without peaks and throughcharacteristic of oral dosing. Efficacy, cycle control, tolerability and side effect profile were comparableto an established oral contraceptive. Compliance with the weekly administered contraceptivepatch was significantly better than with an oral contraceptive. The reliability of adhesion of thepatch is very high and consistent even under varying conditions (heat, humidity, exercise).
transdermal contraception, contraceptive patch, norelgestromin, ethinylestradiol
Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP
Gynaecology and obstetrics